Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
Colorado State University, Fort Collins, CO, USA.
Sci Rep. 2020 Aug 7;10(1):13311. doi: 10.1038/s41598-020-69327-x.
Q-fever is a flu-like illness caused by Coxiella burnetii (Cb), a highly infectious intracellular bacterium. There is an unmet need for a safe and effective vaccine for Q-fever. Correlates of immune protection to Cb infection are limited. We proposed that analysis by longitudinal high dimensional immune (HDI) profiling using mass cytometry combined with other measures of vaccination and protection could be used to identify novel correlates of effective vaccination and control of Cb infection. Using a vaccine-challenge model in HLA-DR transgenic mice, we demonstrated significant alterations in circulating T-cell and innate immune populations that distinguished vaccinated from naïve mice within 10 days, and persisted until at least 35 days post-vaccination. Following challenge, vaccinated mice exhibited reduced bacterial burden and splenomegaly, along with distinct effector T-cell and monocyte profiles. Correlation of HDI data to serological and pathological measurements was performed. Our data indicate a Th1-biased response to Cb, consistent with previous reports, and identify Ly6C, CD73, and T-bet expression in T-cell, NK-cell, and monocytic populations as distinguishing features between vaccinated and naïve mice. This study refines the understanding of the integrated immune response to Cb vaccine and challenge, which can inform the assessment of candidate vaccines for Cb.
Q 热是由柯克斯体(Coxiella burnetii,Cb)引起的类似流感的疾病,Cb 是一种高度传染性的细胞内细菌。目前需要一种安全有效的 Q 热疫苗,但尚未实现。与 Cb 感染免疫保护相关的因素有限。我们提出,使用质谱流式细胞术进行纵向高维免疫(HDI)分析,并结合其他疫苗接种和保护措施的测量,可以用于确定有效的疫苗接种和控制 Cb 感染的新相关因素。在 HLA-DR 转基因小鼠的疫苗挑战模型中,我们证明了循环 T 细胞和先天免疫群体的显著改变,在 10 天内可以区分接种疫苗和未接种疫苗的小鼠,并且至少持续到接种疫苗后 35 天。接种疫苗的小鼠在受到挑战后,细菌负荷和脾肿大减少,同时效应 T 细胞和单核细胞的特征也发生了变化。对 HDI 数据与血清学和病理学测量进行了相关性分析。我们的数据表明,Cb 引发 Th1 偏向性反应,与先前的报告一致,并确定了 T 细胞、NK 细胞和单核细胞群体中 Ly6C、CD73 和 T-bet 表达是区分接种疫苗和未接种疫苗小鼠的特征。这项研究深化了对 Cb 疫苗接种和挑战的综合免疫反应的理解,为评估 Cb 候选疫苗提供了信息。